Terms: = Lymphoma AND SSX1, MGC5162, 6756, ENSG00000126752, RP11-552E4_1, SSRC, MGC150425, Q16384 AND Treatment
27299 results:
1. Efficacy and safety of netupitant/palonosetron in preventing nausea and vomiting in diffuse large B cell lymphoma patients undergoing R-CHOP chemotherapy.
Kwak K; Park Y; Kim BS; Kang KW
Sci Rep; 2024 May; 14(1):11229. PubMed ID: 38755279
[TBL] [Abstract] [Full Text] [Related]
2. Sintilimab (anti-PD-1 antibody) plus chidamide (histone deacetylase inhibitor) in relapsed or refractory extranodal natural killer T-cell lymphoma (SCENT): a phase Ib/II study.
Gao Y; He H; Li X; Zhang L; Xu W; Feng R; Li W; Xiao Y; Liu X; Chen Y; Wang X; Bai B; Wu H; Cai Q; Li Z; Li J; Lin S; He Y; Ping L; Huang C; Mao J; Chen X; Zhao B; Huang H
Signal Transduct Target Ther; 2024 May; 9(1):121. PubMed ID: 38755119
[TBL] [Abstract] [Full Text] [Related]
3. Effectiveness and safety of interferon α-2a combined with phototherapy for patients with early-stage mycosis fungoides - a single-arm prospective study in 13 patients.
Song H; Hu Z; Zhang S; Yang L; Feng J; Lu L; Liu Y; Wang T
J Dermatolog Treat; 2024 Dec; 35(1):2350231. PubMed ID: 38754985
[No Abstract] [Full Text] [Related]
4. Impact of Fee For Service on the Efficiency and Survival of Seguro Popular's Patients With Acute Lymphoblastic Leukemia in Mexico.
Cerecero-García D; Macías-González F; Muñoz-Aguirre P; Huerta-Gutierrez R; Zapata M; Rivera-Luna R; Lajous M; Bautista-Arredondo S
JCO Glob Oncol; 2024 May; 10():e2300060. PubMed ID: 38754053
[TBL] [Abstract] [Full Text] [Related]
5. Evaluation of sex inequity in lung-cancer-specific survival.
Lærum D; Strand TE; Brustugun OT; Gallefoss F; Falk R; Durheim MT; Fjellbirkeland L
Acta Oncol; 2024 May; 63():343-350. PubMed ID: 38751329
[TBL] [Abstract] [Full Text] [Related]
6. Baseline immunoglobulin G and immune function in non-Hodgkin lymphoma: a retrospective analysis.
Brazel D; Grant C; Cabal A; Chen WP; Pinter-Brown L
Front Immunol; 2024; 15():1334899. PubMed ID: 38745669
[TBL] [Abstract] [Full Text] [Related]
7. Prognostic significance of myeloid-derived suppressor cells and systemic inflammation in newly diagnosed diffuse large B cell lymphoma treated with chemoimmunotherapy.
Foureau DM; Guo F; Steuerwald NM; Druhan LJ; Avalos BR; Copelan E; Sun D; Hu B; Moyo T; Jacobs R; Park S; Ghosh N
Exp Hematol; 2024 Jan; 129():104125. PubMed ID: 38743005
[TBL] [Abstract] [Full Text] [Related]
8. Acute Airway Obstruction: An Unusual Presentation of Posttransplant Lymphoproliferative Disorder in a Renal Transplant Recipient.
Aggarwal J; Kumar DJ; Rathore V; Mehta R; Kumar A; Ravina M
Exp Clin Transplant; 2024 Apr; 22(4):307-310. PubMed ID: 38742322
[TBL] [Abstract] [Full Text] [Related]
9. The role of upfront lenalidomide maintenance for primary central nervous system lymphoma following first-line methotrexate treatment: A retrospective study.
Zhang Y; Wang W; Zhao D; Chong W; Chen C; Zhang W; Zhou D
Cancer Med; 2024 May; 13(9):e7193. PubMed ID: 38738459
[TBL] [Abstract] [Full Text] [Related]
10. Distinct autoantibody profiles across checkpoint inhibitor types and toxicities.
Mu-Mosley H; von Itzstein MS; Fattah F; Liu J; Zhu C; Xie Y; Wakeland EK; Park JY; Kahl BS; Diefenbach CS; Gerber DE
Oncoimmunology; 2024; 13(1):2351255. PubMed ID: 38737792
[TBL] [Abstract] [Full Text] [Related]
11. In Vivo, In Vitro and In Silico Anticancer Activity of Ilama Leaves: An Edible and Medicinal Plant in Mexico.
Ramírez-Santos J; Calzada F; Ordoñez-Razo RM; Mendieta-Wejebe JE; Velázquez-Domínguez JA; Argüello-García R; Velázquez C; Barbosa E
Molecules; 2024 Apr; 29(9):. PubMed ID: 38731446
[TBL] [Abstract] [Full Text] [Related]
12. Paradigm Shifts in Hodgkin lymphoma treatment: From Frontline Therapies to Relapsed Disease.
Burton C; Allen P; Herrera AF
Am Soc Clin Oncol Educ Book; 2024 Jun; 44(3):e433502. PubMed ID: 38728605
[TBL] [Abstract] [Full Text] [Related]
13. Primary colon lymphomas: An analysis of our experience over the last 18 years.
Hasturk D; Akturk Esen S; Buyukaksoy M; Civelek B; Seven I; Uncu D
Medicine (Baltimore); 2024 May; 103(19):e38013. PubMed ID: 38728507
[TBL] [Abstract] [Full Text] [Related]
14. Sodium arsenite and arsenic trioxide differently affect the oxidative stress of lymphoblastoid cells: An intricate crosstalk between mitochondria, autophagy and cell death.
Rainey NE; Armand AS; Petit PX
PLoS One; 2024; 19(5):e0302701. PubMed ID: 38728286
[TBL] [Abstract] [Full Text] [Related]
15. Systematic analysis of mucosal-associated invariant T cells in haematological malignancies.
Bacova B; Cierny J; Nemcekova L; Smetanova/Brozova J; Novak J
Scand J Immunol; 2024 Jun; 99(6):e13364. PubMed ID: 38720521
[TBL] [Abstract] [Full Text] [Related]
16. [The value of minimal residual disease and IKZF1 deletion for predicting prognosis in adult patients with B-cell acute lymphoblastic leukemia].
Deng SY; Ou JW; Huang ZC; Chen JJ; Cai ZH; Liu QF; Zhou HS
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):257-263. PubMed ID: 38716597
[No Abstract] [Full Text] [Related]
17. [Efficacy of allogeneic hematopoietic stem cell transplantation based on a total body irradiation conditioning treatment regimen for adult acute lymphocytic leukemia].
Xiao QQ; Yu XL; Song XC; Hou YX; Deng L; Li WJ; Zhou F
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):249-256. PubMed ID: 38716596
[No Abstract] [Full Text] [Related]
18. [The clinical features, survival analysis, and geriatric assessment of 85 patients with follicular lymphoma: a single-center study].
Yin JJ; Qian L; Bai JF; Feng R; Li JT; Wang T; Zhang CL; Liu H
Zhonghua Xue Ye Xue Za Zhi; 2024 Mar; 45(3):233-241. PubMed ID: 38716594
[No Abstract] [Full Text] [Related]
19. Multiomics analysis identifies oxidative phosphorylation as a cancer vulnerability arising from myristoylation inhibition.
Beauchamp E; Gamma JM; Cromwell CR; Moussa EW; Pain R; Kostiuk MA; Acevedo-Morantes C; Iyer A; Yap M; Vincent KM; Postovit LM; Julien O; Hubbard BP; Mackey JR; Berthiaume LG
J Transl Med; 2024 May; 22(1):431. PubMed ID: 38715059
[TBL] [Abstract] [Full Text] [Related]
20. Intravenous immunoglobulins for the treatment of prolonged COVID-19 in immunocompromised patients: a brief report.
Billi B; Cholley P; Grobost V; Clément M; Rieu V; Le Guenno G; Lobbes H
Front Immunol; 2024; 15():1399180. PubMed ID: 38707896
[TBL] [Abstract] [Full Text] [Related]
[Next]